Vaccines issue

Nurenburg principles you need to ask permission from

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: om FDA definable end point for people to tell whether it is effective or not Ethical issue is significant when phase 3 patients are in developing country (it is cheaper). Test is new stuff vs. standard treatment, and in developing country, standard treatment is nothing, so what do you test against??? 4) Post- Market surveillance: company can only push drug for initial intended indication. Nurenburg Principles: you need to ask permission from...
View Full Document

Ask a homework question - tutors are online